메뉴 건너뛰기




Volumn 8, Issue 11, 2010, Pages 1228-1274

Thyroid carcinoma

(25)  Tuttle, R Michael a   Ball, Douglas W b   Byrd, David c   Dilawari, Raza A d   Doherty, Gerard M e   Duh, Quan Yang f   Ehya, Hormoz g   Farrar, William B h   Haddad, Robert I i   Kandeel, Fouad j   Kloos, Richard T h   Kopp, Peter k   Lamonica, Dominick M l   Loree, Thom R l   Lydiatt, William M m   McCaffrey, Judith C n   Olson Jr , John A o   Parks, Lee p   Ridge, John A g   Shah, Jatin P a   more..


Author keywords

Anaplastic thyroid cancer; Cancer; Follicular cancer; H rthle cell carcinoma; Malignancy; Medullary thyroid cancer; NCCN clinical practice guidelines; NCCN guidelines; Papillary thyroid cancer; Radioactive; Thyroid gland; Thyroidectomy; Tumor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AXITINIB; BISPHOSPHONIC ACID DERIVATIVE; BORTEZOMIB; CALCIUM; COMBRETASTATIN A4 PHOSPHATE; CS 7107; DEPSIPEPTIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE; IODINE 131; LENALIDOMIDE; LEVOTHYROXINE; MOTESANIB; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RECOMBINANT THYROTROPIN; SORAFENIB; SUNITINIB; TANESPIMYCIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; UNCLASSIFIED DRUG; VANDETANIB; VITAMIN D; VORINOSTAT;

EID: 78951486191     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0093     Document Type: Review
Times cited : (206)

References (213)
  • 1
    • 0002849112 scopus 로고
    • Thyroid carcinoma: Papillary and follicular
    • Mazzaferri EL, Samaan N, eds. Cambridge, United Kingdom: Blackwell Scientific Publications
    • Mazzaferri EL. Thyroid carcinoma: papillary and follicular. In: Mazzaferri EL, Samaan N, eds. Endocrine Tumors. Cambridge, United Kingdom: Blackwell Scientific Publications; 1993:278-333.
    • (1993) Endocrine Tumors , pp. 278-333
    • Mazzaferri, E.L.1
  • 2
    • 6044243265 scopus 로고    scopus 로고
    • Clinical practice. The thyroid nodule
    • Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-1771.
    • (2004) N Engl J Med , vol.351 , pp. 1764-1771
    • Hegedus, L.1
  • 3
    • 33645465719 scopus 로고    scopus 로고
    • Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    • Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-142.
    • (2006) Thyroid , vol.16 , pp. 109-142
    • Cooper, D.S.1    Doherty, G.M.2    Haugen, B.R.3
  • 4
    • 0028015844 scopus 로고
    • Thyroid incidentalomas. Prevalence by palpation and ultrasonography
    • Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994;154:1838-1840.
    • (1994) Arch Intern Med , vol.154 , pp. 1838-1840
    • Ezzat, S.1    Sarti, D.A.2    Cain, D.R.3    Braunstein, G.D.4
  • 5
    • 0028963996 scopus 로고
    • Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies
    • Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141:259-277.
    • (1995) Radiat Res , vol.141 , pp. 259-277
    • Ron, E.1    Lubin, J.H.2    Shore, R.E.3
  • 6
    • 0030830392 scopus 로고    scopus 로고
    • Thyroid nodules in the follow-up of irradiated individuals: Comparison of thyroid ultrasound with scanning and palpation
    • Schneider AB, Bekerman C, Leland J, et al. Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 1997;82:4020-4027.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 4020-4027
    • Schneider, A.B.1    Bekerman, C.2    Leland, J.3
  • 7
    • 67650584040 scopus 로고    scopus 로고
    • National Cancer Institute. Bethesda, MD. Available at: based on November 2008 SEER data submission, posted to the SEER web site, Accessed October 6, 2010
    • Horner MJ, Ries LAG, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009. Accessed October 6, 2010.
    • (2009) SEER Cancer Statistics Review, 1975-2006
    • Horner, M.J.1    Ries, L.A.G.2    Krapcho, M.3
  • 9
    • 0037986206 scopus 로고    scopus 로고
    • Cancer incidence in adolescents and young adults in the United States, 1992-1997
    • Wu XC, Chen VW, Steele B, et al. Cancer incidence in adolescents and young adults in the United States, 1992-1997. J Adolesc Health 2003;32:405-415.
    • (2003) J Adolesc Health , vol.32 , pp. 405-415
    • Wu, X.C.1    Chen, V.W.2    Steele, B.3
  • 10
    • 21244439201 scopus 로고    scopus 로고
    • Cancer incidence patterns among adolescents and young adults in the United States
    • Wu X, Groves FD, McLaughlin CC, et al. Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control 2005;16:309-320.
    • (2005) Cancer Causes Control , vol.16 , pp. 309-320
    • Wu, X.1    Groves, F.D.2    McLaughlin, C.C.3
  • 11
    • 33745650671 scopus 로고    scopus 로고
    • Cancer in 15- to 29-year-olds by primary site
    • Bleyer A, Viny A, Barr R. Cancer in 15- to 29-year-olds by primary site. Oncologist 2006;11:590-601.
    • (2006) Oncologist , vol.11 , pp. 590-601
    • Bleyer, A.1    Viny, A.2    Barr, R.3
  • 12
    • 0032535770 scopus 로고    scopus 로고
    • A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
    • Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-2648.
    • (1998) Cancer , vol.83 , pp. 2638-2648
    • Hundahl, S.A.1    Fleming, I.D.2    Fremgen, A.M.3    Menck, H.R.4
  • 13
    • 0027943619 scopus 로고
    • Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
    • Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
    • (1994) Am J Med , vol.97 , pp. 418-428
    • Mazzaferri, E.L.1    Jhiang, S.M.2
  • 14
    • 33646442046 scopus 로고    scopus 로고
    • Increasing incidence of thyroid cancer in the United States, 1973-2002
    • Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-2167.
    • (2006) JAMA , vol.295 , pp. 2164-2167
    • Davies, L.1    Welch, H.G.2
  • 15
    • 12144284838 scopus 로고    scopus 로고
    • Papillary microcarcinoma of the thyroid: How should it be treated?
    • Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 2004;28:1115-1121.
    • (2004) World J Surg , vol.28 , pp. 1115-1121
    • Ito, Y.1    Tomoda, C.2    Uruno, T.3
  • 16
    • 68549099879 scopus 로고    scopus 로고
    • Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005
    • Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115:3801-3807.
    • (2009) Cancer , vol.115 , pp. 3801-3807
    • Chen, A.Y.1    Jemal, A.2    Ward, E.M.3
  • 17
    • 64549114616 scopus 로고    scopus 로고
    • Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005
    • Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009;18:784-791.
    • (2009) Cancer Epidemiol Biomarkers Prev , vol.18 , pp. 784-791
    • Enewold, L.1    Zhu, K.2    Ron, E.3
  • 18
    • 0037425748 scopus 로고    scopus 로고
    • Thyroid carcinoma
    • Sherman SI. Thyroid carcinoma. Lancet 2003;361:501-511.
    • (2003) Lancet , vol.361 , pp. 501-511
    • Sherman, S.I.1
  • 19
    • 10244253980 scopus 로고    scopus 로고
    • Benign thyroid tumors: General risk factors and their effects on radiation risk estimation
    • Wong FL, Ron E, Gierlowski T, Schneider AB. Benign thyroid tumors: general risk factors and their effects on radiation risk estimation. Am J Epidemiol 1996;144:728-733.
    • (1996) Am J Epidemiol , vol.144 , pp. 728-733
    • Wong, F.L.1    Ron, E.2    Gierlowski, T.3    Schneider, A.B.4
  • 20
    • 0032578119 scopus 로고    scopus 로고
    • Cancer mortality following treatment for adult hyperthyroidism
    • Cooperative Thyrotoxicosis Therapy Follow-up Study Group
    • Ron E, Doody MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998;280:347-355.
    • (1998) JAMA , vol.280 , pp. 347-355
    • Ron, E.1    Doody, M.M.2    Becker, D.V.3
  • 21
    • 0032485498 scopus 로고    scopus 로고
    • Thyroid cancer risk to children calculated
    • Jacob P, Goulko G, Heidenreich WF, et al. Thyroid cancer risk to children calculated. Nature 1998;392:31-32.
    • (1998) Nature , vol.392 , pp. 31-32
    • Jacob, P.1    Goulko, G.2    Heidenreich, W.F.3
  • 23
    • 0032532220 scopus 로고    scopus 로고
    • Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas
    • Nikiforov YE, Nikiforova M, Fagin JA. Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas. Oncogene 1998;17:1983-1988.
    • (1998) Oncogene , vol.17 , pp. 1983-1988
    • Nikiforov, Y.E.1    Nikiforova, M.2    Fagin, J.A.3
  • 24
    • 21844441016 scopus 로고    scopus 로고
    • Clinical evaluation and management of solitary thyroid nodules
    • Braverman LE, Utiger RD, eds. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins
    • Kaplan MM. Clinical evaluation and management of solitary thyroid nodules. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:996-1010.
    • (2005) Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text , pp. 996-1010
    • Kaplan, M.M.1
  • 26
    • 0038702077 scopus 로고    scopus 로고
    • An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid
    • Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-387.
    • (2003) Thyroid , vol.13 , pp. 381-387
    • Ito, Y.1    Uruno, T.2    Nakano, K.3
  • 27
    • 0031038707 scopus 로고    scopus 로고
    • Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging
    • Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226-231.
    • (1997) Ann Intern Med , vol.126 , pp. 226-231
    • Tan, G.H.1    Gharib, H.2
  • 28
    • 27744572522 scopus 로고    scopus 로고
    • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement
    • Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005;237:794-800.
    • (2005) Radiology , vol.237 , pp. 794-800
    • Frates, M.C.1    Benson, C.B.2    Charboneau, J.W.3
  • 29
    • 0026670242 scopus 로고
    • Thyroid cancer in thyroid nodules: Finding a needle in the haystack
    • Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992;93:359-362.
    • (1992) Am J Med , vol.93 , pp. 359-362
    • Mazzaferri, E.L.1
  • 30
    • 0025214027 scopus 로고
    • The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds
    • Hamming JF, Goslings BM, van Steenis GJ, et al. The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 1990;150:113-116.
    • (1990) Arch Intern Med , vol.150 , pp. 113-116
    • Hamming, J.F.1    Goslings, B.M.2    Van Steenis, G.J.3
  • 31
    • 0141864472 scopus 로고    scopus 로고
    • Common and uncommon sonographic features of papillary thyroid carcinoma
    • Chan BK, Desser TS, McDougall IR, et al. Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med 2003;22:1083-1090.
    • (2003) J Ultrasound Med , vol.22 , pp. 1083-1090
    • Chan, B.K.1    Desser, T.S.2    McDougall, I.R.3
  • 32
    • 40849106396 scopus 로고    scopus 로고
    • Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage
    • Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008;93:809-814.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 809-814
    • Haymart, M.R.1    Repplinger, D.J.2    Leverson, G.E.3
  • 33
    • 0030566325 scopus 로고    scopus 로고
    • Early diagnosis of sporadic medullary cancers of the thyroid: Value of systematic assay of calcitonin
    • in French
    • Henry JF, Denizot A, Puccini M, et al. [Early diagnosis of sporadic medullary cancers of the thyroid: value of systematic assay of calcitonin]. Presse Med 1996;25:1583-1588 [in French].
    • (1996) Presse Med , vol.25 , pp. 1583-1588
    • Henry, J.F.1    Denizot, A.2    Puccini, M.3
  • 34
    • 70449370231 scopus 로고    scopus 로고
    • Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    • Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214.
    • (2009) Thyroid , vol.19 , pp. 1167-1214
    • Cooper, D.S.1    Doherty, G.M.2    Haugen, B.R.3
  • 35
    • 45149088749 scopus 로고    scopus 로고
    • Calcitonin measurement in the evaluation of thyroid nodules in the United States: A cost-effectiveness and decision analysis
    • Cheung K, Roman SA, Wang TS, et al. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 2008;93:2173-2180.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 2173-2180
    • Cheung, K.1    Roman, S.A.2    Wang, T.S.3
  • 36
    • 0035089670 scopus 로고    scopus 로고
    • Ultrasonographic characteristics of thyroid nodules: Prediction of malignancy
    • Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 2001;136:334-337.
    • (2001) Arch Surg , vol.136 , pp. 334-337
    • Koike, E.1    Noguchi, S.2    Yamashita, H.3
  • 37
    • 43149085821 scopus 로고    scopus 로고
    • The National Cancer Institute thyroid fine needle aspiration state of the science conference: A summation
    • Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 2008;5:6.
    • (2008) Cytojournal , vol.5 , pp. 6
    • Baloch, Z.W.1    Cibas, E.S.2    Clark, D.P.3
  • 38
    • 1842429850 scopus 로고    scopus 로고
    • False-negative fineneedle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma
    • Yeh MW, Demircan O, Ituarte P, Clark OH. False-negative fineneedle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 2004;14:207-215.
    • (2004) Thyroid , vol.14 , pp. 207-215
    • Yeh, M.W.1    Demircan, O.2    Ituarte, P.3    Clark, O.H.4
  • 39
    • 0008329558 scopus 로고    scopus 로고
    • Fine-needle aspiration cytology and histopathology
    • Clark OH, Noguchi S, eds. St Louis, MO: Quality Medical Publishing
    • Asa SL, Bedard YC. Fine-needle aspiration cytology and histopathology. In: Clark OH, Noguchi S, eds. Thyroid Cancer: Diagnosis and Treatment. St Louis, MO: Quality Medical Publishing; 2000:105-126.
    • (2000) Thyroid Cancer: Diagnosis and Treatment , pp. 105-126
    • Asa, S.L.1    Bedard, Y.C.2
  • 40
    • 0036137843 scopus 로고    scopus 로고
    • Diagnosis of "follicular neoplasm": A gray zone in thyroid fine-needle aspiration cytology
    • Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26:41-44.
    • (2002) Diagn Cytopathol , vol.26 , pp. 41-44
    • Baloch, Z.W.1    Fleisher, S.2    LiVolsi, V.A.3    Gupta, P.K.4
  • 41
    • 0027479536 scopus 로고
    • "Suspicious" thyroid cytologic findings: Outcome in patients without immediate surgical treatment
    • Cersosimo E, Gharib H, Suman VJ, Goellner JR. "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc 1993;68:343-348.
    • (1993) Mayo Clin Proc , vol.68 , pp. 343-348
    • Cersosimo, E.1    Gharib, H.2    Suman, V.J.3    Goellner, J.R.4
  • 42
    • 0027196498 scopus 로고
    • Non-diagnostic fine needle aspiration biopsy: A dilemma in management of nodular thyroid disease
    • McHenry CR, Walfish PG, Rosen IB. Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg 1993;59:415-419.
    • (1993) Am Surg , vol.59 , pp. 415-419
    • McHenry, C.R.1    Walfish, P.G.2    Rosen, I.B.3
  • 43
    • 0031879825 scopus 로고    scopus 로고
    • Differentiated thyroid cancer: Determinants of disease progression in patients <21 years of age at diagnosis: A report from the Surgical Discipline Committee of the Children's Cancer Group
    • Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 1998;227:533-541.
    • (1998) Ann Surg , vol.227 , pp. 533-541
    • Newman, K.D.1    Black, T.2    Heller, G.3
  • 44
    • 0031815313 scopus 로고    scopus 로고
    • The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer
    • discussion 1139-1140
    • Robie DK, Dinauer CW, Tuttle RM, et al. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer. J Pediatr Surg 1998;33:1134-1138; discussion 1139-1140.
    • (1998) J Pediatr Surg , vol.33 , pp. 1134-1138
    • Robie, D.K.1    Dinauer, C.W.2    Tuttle, R.M.3
  • 45
    • 0031028402 scopus 로고    scopus 로고
    • Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991
    • Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997;79:564-573.
    • (1997) Cancer , vol.79 , pp. 564-573
    • Gilliland, F.D.1    Hunt, W.C.2    Morris, D.M.3    Key, C.R.4
  • 46
    • 0032169341 scopus 로고    scopus 로고
    • Prospective multicenter study of thyroid carcinoma treatment: Initial analysis of staging and outcome
    • National Thyroid Cancer Treatment Cooperative Study Registry Group
    • Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 1998;83:1012-1021.
    • (1998) Cancer , vol.83 , pp. 1012-1021
    • Sherman, S.I.1    Brierley, J.D.2    Sperling, M.3
  • 47
    • 0031963901 scopus 로고    scopus 로고
    • The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
    • Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998;82:375-388.
    • (1998) Cancer , vol.82 , pp. 375-388
    • Tsang, R.W.1    Brierley, J.D.2    Simpson, W.J.3
  • 48
    • 0027465843 scopus 로고
    • Management of a solitary thyroid nodule
    • Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-559.
    • (1993) N Engl J Med , vol.328 , pp. 553-559
    • Mazzaferri, E.L.1
  • 49
    • 0030926257 scopus 로고    scopus 로고
    • Differentiated thyroid carcinoma in children and adolescents: A 37-year experience in 85 patients
    • Dottorini ME, Vignati A, Mazzucchelli L, et al. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 1997;38:669-675.
    • (1997) J Nucl Med , vol.38 , pp. 669-675
    • Dottorini, M.E.1    Vignati, A.2    Mazzucchelli, L.3
  • 50
    • 0031710453 scopus 로고    scopus 로고
    • Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer
    • Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39:1531-1536.
    • (1998) J Nucl Med , vol.39 , pp. 1531-1536
    • Samuel, A.M.1    Rajashekharrao, B.2    Shah, D.H.3
  • 51
    • 0023584245 scopus 로고
    • Differentiated thyroid carcinoma in childhood: Long term follow-up of 72 patients
    • Schlumberger M, De Vathaire F, Travagli JP, et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987;65:1088-1094.
    • (1987) J Clin Endocrinol Metab , vol.65 , pp. 1088-1094
    • Schlumberger, M.1    De Vathaire, F.2    Travagli, J.P.3
  • 52
    • 0027135424 scopus 로고
    • Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
    • discussion 1057-1058
    • Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1057; discussion 1057-1058.
    • (1993) Surgery , vol.114 , pp. 1050-1057
    • Hay, I.D.1    Bergstralh, E.J.2    Goellner, J.R.3
  • 53
    • 0028827189 scopus 로고
    • Prognostic factors and risk group analysis in follicular carcinoma of the thyroid
    • discussion 1136-1138
    • Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995;118:1131-1136; discussion 1136-1138.
    • (1995) Surgery , vol.118 , pp. 1131-1136
    • Shaha, A.R.1    Loree, T.R.2    Shah, J.P.3
  • 54
    • 0032168076 scopus 로고    scopus 로고
    • Staging in thyroid carcinoma
    • Cady B. Staging in thyroid carcinoma. Cancer 1998;83:844-847.
    • (1998) Cancer , vol.83 , pp. 844-847
    • Cady, B.1
  • 55
    • 0028208381 scopus 로고
    • Does the method of management of papillary thyroid carcinoma make a difference in outcome?
    • DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994;18:123-130.
    • (1994) World J Surg , vol.18 , pp. 123-130
    • DeGroot, L.J.1    Kaplan, E.L.2    Straus, F.H.3    Shukla, M.S.4
  • 56
    • 0031962574 scopus 로고    scopus 로고
    • Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident
    • Miccoli P, Antonelli A, Spinelli C, et al. Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident. Arch Surg 1998;133:89-93.
    • (1998) Arch Surg , vol.133 , pp. 89-93
    • Miccoli, P.1    Antonelli, A.2    Spinelli, C.3
  • 57
    • 3142717545 scopus 로고    scopus 로고
    • Management and outcome of recurrent well-differentiated thyroid carcinoma
    • Palme CE, Waseem Z, Raza SN, et al. Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:819-824.
    • (2004) Arch Otolaryngol Head Neck Surg , vol.130 , pp. 819-824
    • Palme, C.E.1    Waseem, Z.2    Raza, S.N.3
  • 58
    • 0025500411 scopus 로고
    • Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients
    • Frankenthaler RA, Sellin RV, Cangir A, Goepfert H. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg 1990;160:341-343.
    • (1990) Am J Surg , vol.160 , pp. 341-343
    • Frankenthaler, R.A.1    Sellin, R.V.2    Cangir, A.3    Goepfert, H.4
  • 59
    • 26244435937 scopus 로고    scopus 로고
    • Familial risks for nonmedullary thyroid cancer
    • Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005;90:5747-5753.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 5747-5753
    • Hemminki, K.1    Eng, C.2    Chen, B.3
  • 60
    • 0025001249 scopus 로고
    • Multiple primary malignant tumours: Gemistocytic astrocytoma with leptomeningeal spreading and papillary thyroid carcinoma. A case report
    • Napoli
    • Agostini L, Mazzi P, Cavaliere A. Multiple primary malignant tumours: gemistocytic astrocytoma with leptomeningeal spreading and papillary thyroid carcinoma. A case report. Acta Neurol (Napoli) 1990;12:305-310.
    • (1990) Acta Neurol , vol.12 , pp. 305-310
    • Agostini, L.1    Mazzi, P.2    Cavaliere, A.3
  • 61
    • 0032893765 scopus 로고    scopus 로고
    • Familial adenomatous polyposis-associated thyroid cancer: A clinical, pathological, and molecular genetics study
    • Soravia C, Sugg SL, Berk T, et al. Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol 1999;154:127-135.
    • (1999) Am J Pathol , vol.154 , pp. 127-135
    • Soravia, C.1    Sugg, S.L.2    Berk, T.3
  • 62
    • 0030835716 scopus 로고    scopus 로고
    • Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex)
    • Stratakis CA, Courcoutsakis NA, Abati A, et al. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 1997;82:2037-2043.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 2037-2043
    • Stratakis, C.A.1    Courcoutsakis, N.A.2    Abati, A.3
  • 63
    • 17344368045 scopus 로고    scopus 로고
    • Germline PTEN mutations in Cowden syndrome-like families
    • Marsh DJ, Dahia PL, Caron S, et al. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet 1998;35:881-885.
    • (1998) J Med Genet , vol.35 , pp. 881-885
    • Marsh, D.J.1    Dahia, P.L.2    Caron, S.3
  • 64
    • 0023408270 scopus 로고
    • Papillary thyroid carcinoma: Factors influencing prognosis and current therapy
    • Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14:315-332.
    • (1987) Semin Oncol , vol.14 , pp. 315-332
    • Mazzaferri, E.L.1
  • 65
    • 0001332844 scopus 로고
    • Follicular lesions of the thyroid
    • LiVolsi VA, ed. Philadelphia, PA: WB Saunders
    • LiVolsi VA. Follicular lesions of the thyroid. In: LiVolsi VA, ed. Surgical Pathology of the Thyroid. Philadelphia, PA: WB Saunders; 1990:173-212.
    • (1990) Surgical Pathology of the Thyroid , pp. 173-212
    • LiVolsi, V.A.1
  • 66
    • 0000412394 scopus 로고
    • Papillary lesions of the thyroid
    • LiVolsi VA, ed. Philadelphia, PA: WB Saunders
    • LiVolsi VA. Papillary lesions of the thyroid. In: LiVolsi VA, ed. Surgical Pathology of the Thyroid. Philadelphia, PA: WB Saunders; 1990:136-172.
    • (1990) Surgical Pathology of the Thyroid , pp. 136-172
    • LiVolsi, V.A.1
  • 67
    • 0029185570 scopus 로고
    • Unusual variants of papillary thyroid carcinoma
    • Mazzaferri EL, Kreisberg RA, Bar RS, eds. St. Louis, MO: Mosby-Year Book
    • LiVolsi VA. Unusual variants of papillary thyroid carcinoma. In: Mazzaferri EL, Kreisberg RA, Bar RS, eds. Advances in Endocrinology and Metabolism. St. Louis, MO: Mosby-Year Book; 1994:39-54.
    • (1994) Advances in Endocrinology and Metabolism , pp. 39-54
    • LiVolsi, V.A.1
  • 68
    • 0027954242 scopus 로고
    • Follicular variant of papillary thyroid carcinoma. A clinicopathologic study
    • Tielens ET, Sherman SI, Hruban RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 1994;73:424-431.
    • (1994) Cancer , vol.73 , pp. 424-431
    • Tielens, E.T.1    Sherman, S.I.2    Hruban, R.H.3    Ladenson, P.W.4
  • 69
    • 33749012811 scopus 로고    scopus 로고
    • Follicular variant of papillary thyroid carcinoma: A clinicopathologic study of a problematic entity
    • Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 2006;107:1255-1264.
    • (2006) Cancer , vol.107 , pp. 1255-1264
    • Liu, J.1    Singh, B.2    Tallini, G.3
  • 70
    • 0027102237 scopus 로고
    • Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy
    • discussion 1136-1138
    • van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 1992;112:1130-1136; discussion 1136-1138.
    • (1992) Surgery , vol.112 , pp. 1130-1136
    • Van Heerden, J.A.1    Hay, I.D.2    Goellner, J.R.3
  • 71
    • 0028302349 scopus 로고
    • The demise of follicular carcinoma of the thyroid gland
    • LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid 1994;4:233-236.
    • (1994) Thyroid , vol.4 , pp. 233-236
    • LiVolsi, V.A.1    Asa, S.L.2
  • 72
    • 0026065478 scopus 로고
    • Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome
    • Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991;66:11-22.
    • (1991) Mayo Clin Proc , vol.66 , pp. 11-22
    • Brennan, M.D.1    Bergstralh, E.J.2    Van Heerden, J.A.3    McConahey, W.M.4
  • 76
    • 0027303892 scopus 로고
    • Problems in the classification of thyroid tumors. Their significance for prognosis and therapy
    • in German
    • Hedinger CE. [Problems in the classification of thyroid tumors. Their significance for prognosis and therapy]. Schweiz Med Wochenschr 1993;123:1673-1681 [in German].
    • (1993) Schweiz Med Wochenschr , vol.123 , pp. 1673-1681
    • Hedinger, C.E.1
  • 77
    • 0036118397 scopus 로고    scopus 로고
    • Hurthle cell tumors: Using molecular techniques to define a novel classification system
    • Belchetz G, Cheung CC, Freeman J, et al. Hurthle cell tumors: using molecular techniques to define a novel classification system. Arch Otolaryngol Head Neck Surg 2002;128:237-240.
    • (2002) Arch Otolaryngol Head Neck Surg , vol.128 , pp. 237-240
    • Belchetz, G.1    Cheung, C.C.2    Freeman, J.3
  • 78
    • 0031596670 scopus 로고    scopus 로고
    • Hurthle cell neoplasms of the thyroid: Are there factors predictive of malignancy?
    • Chen H, Nicol TL, Zeiger MA, et al. Hurthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg 1998;227:542-546.
    • (1998) Ann Surg , vol.227 , pp. 542-546
    • Chen, H.1    Nicol, T.L.2    Zeiger, M.A.3
  • 80
    • 0037369140 scopus 로고    scopus 로고
    • Prognostic factors in patients with Hurthle cell neoplasms of the thyroid
    • Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 2003;97:1186-1194.
    • (2003) Cancer , vol.97 , pp. 1186-1194
    • Lopez-Penabad, L.1    Chiu, A.C.2    Hoff, A.O.3
  • 81
    • 0032587215 scopus 로고    scopus 로고
    • Hurthle cell carcinoma: A malignancy of low-grade potential
    • Khafif A, Khafif RA, Attie JN. Hurthle cell carcinoma: a malignancy of low-grade potential. Head Neck 1999;21:506-511.
    • (1999) Head Neck , vol.21 , pp. 506-511
    • Khafif, A.1    Khafif, R.A.2    Attie, J.N.3
  • 82
    • 0023689451 scopus 로고
    • Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables
    • Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508.
    • (1988) J Clin Endocrinol Metab , vol.67 , pp. 501-508
    • Ruegemer, J.J.1    Hay, I.D.2    Bergstralh, E.J.3
  • 83
    • 0026768192 scopus 로고
    • The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients
    • Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714-720.
    • (1992) J Clin Endocrinol Metab , vol.75 , pp. 714-720
    • Samaan, N.A.1    Schultz, P.N.2    Hickey, R.C.3
  • 84
    • 0021978711 scopus 로고
    • Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients
    • Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985;60:376-380.
    • (1985) J Clin Endocrinol Metab , vol.60 , pp. 376-380
    • Samaan, N.A.1    Schultz, P.N.2    Haynie, T.P.3    Ordonez, N.G.4
  • 85
    • 0007484542 scopus 로고    scopus 로고
    • Microcarcinoma of the thyroid gland: The Gustave-Roussy Institute experience
    • Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 1998;83:553-559.
    • (1998) Cancer , vol.83 , pp. 553-559
    • Baudin, E.1    Travagli, J.P.2    Ropers, J.3
  • 86
  • 88
    • 0027421148 scopus 로고
    • Diagnosis, treatment, and outcome of follicular thyroid carcinoma
    • Emerick GT, Duh QY, Siperstein AE, et al. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 1993;72:3287-3295.
    • (1993) Cancer , vol.72 , pp. 3287-3295
    • Emerick, G.T.1    Duh, Q.Y.2    Siperstein, A.E.3
  • 89
    • 0027097967 scopus 로고
    • Papillary thyroid carcinoma: A multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system
    • Salvesen H, Njolstad PR, Akslen LA, et al. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 1992;158:583-589.
    • (1992) Eur J Surg , vol.158 , pp. 583-589
    • Salvesen, H.1    Njolstad, P.R.2    Akslen, L.A.3
  • 90
    • 0036858294 scopus 로고    scopus 로고
    • Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: A common occurrence
    • Pingpank JF Jr, Sasson AR, Hanlon AL, et al. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence. Arch Otolaryngol Head Neck Surg 2002;128:1275-1278.
    • (2002) Arch Otolaryngol Head Neck Surg , vol.128 , pp. 1275-1278
    • Pingpank Jr., J.F.1    Sasson, A.R.2    Hanlon, A.L.3
  • 91
    • 0031454232 scopus 로고    scopus 로고
    • Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma
    • Yamashita H, Noguchi S, Murakami N, et al. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 1997;80:2268-2272.
    • (1997) Cancer , vol.80 , pp. 2268-2272
    • Yamashita, H.1    Noguchi, S.2    Murakami, N.3
  • 92
    • 0027034109 scopus 로고
    • Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer
    • Sellers M, Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992;164:578-581.
    • (1992) Am J Surg , vol.164 , pp. 578-581
    • Sellers, M.1    Beenken, S.2    Blankenship, A.3
  • 93
    • 0023818273 scopus 로고
    • Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma
    • Lindegaard MW, Paus E, Hoie J, et al. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma. Acta Chir Scand 1988;154:141-145.
    • (1988) Acta Chir Scand , vol.154 , pp. 141-145
    • Lindegaard, M.W.1    Paus, E.2    Hoie, J.3
  • 95
    • 0029911377 scopus 로고    scopus 로고
    • 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma
    • Sisson JC, Giordano TJ, Jamadar DA, et al. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer 1996;78:2184-2192.
    • (1996) Cancer , vol.78 , pp. 2184-2192
    • Sisson, J.C.1    Giordano, T.J.2    Jamadar, D.A.3
  • 96
    • 0021333920 scopus 로고
    • Radioiodine treatment of metastatic thyroid carcinoma: The Royal Marsden Hospital experience
    • Brown AP, Greening WP, McCready VR, et al. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984;57:323-327.
    • (1984) Br J Radiol , vol.57 , pp. 323-327
    • Brown, A.P.1    Greening, W.P.2    McCready, V.R.3
  • 97
    • 0027429811 scopus 로고
    • Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables
    • Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993;34:1626-1631.
    • (1993) J Nucl Med , vol.34 , pp. 1626-1631
    • Casara, D.1    Rubello, D.2    Saladini, G.3
  • 98
    • 0031278763 scopus 로고    scopus 로고
    • Our AMES is true: How an old concept still hits the mark: Or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer
    • Hayes Martin Lecture
    • Cady B. Hayes Martin Lecture. Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997;174:462-468.
    • (1997) Am J Surg , vol.174 , pp. 462-468
    • Cady, B.1
  • 99
    • 0018388868 scopus 로고
    • Risk factor analysis in differentiated thyroid cancer
    • Cady B, Sedgwick CE, Meissner WA, et al. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810-820.
    • (1979) Cancer , vol.43 , pp. 810-820
    • Cady, B.1    Sedgwick, C.E.2    Meissner, W.A.3
  • 100
    • 0030726290 scopus 로고    scopus 로고
    • Pathological tumor-nodemetastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients
    • Loh KC, Greenspan FS, Gee L, et al. Pathological tumor-nodemetastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82:3553-3562.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 3553-3562
    • Loh, K.C.1    Greenspan, F.S.2    Gee, L.3
  • 101
    • 0031847788 scopus 로고    scopus 로고
    • Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma
    • Lin JD, Kao PF, Weng HF, et al. Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma. Eur J Nucl Med 1998;25:695-700.
    • (1998) Eur J Nucl Med , vol.25 , pp. 695-700
    • Lin, J.D.1    Kao, P.F.2    Weng, H.F.3
  • 102
    • 0030978006 scopus 로고    scopus 로고
    • A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example
    • Brierley JD, Panzarella T, Tsang RW, et al. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer 1997;79:2414-2423.
    • (1997) Cancer , vol.79 , pp. 2414-2423
    • Brierley, J.D.1    Panzarella, T.2    Tsang, R.W.3
  • 103
    • 0031752735 scopus 로고    scopus 로고
    • Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma
    • Sherman SI. Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma. Semin Surg Oncol 1999;16:12-15.
    • (1999) Semin Surg Oncol , vol.16 , pp. 12-15
    • Sherman, S.I.1
  • 104
    • 0023521529 scopus 로고
    • Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system
    • Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
    • (1987) Surgery , vol.102 , pp. 1088-1095
    • Hay, I.D.1    Grant, C.S.2    Taylor, W.F.3    McConahey, W.M.4
  • 105
    • 0031762998 scopus 로고    scopus 로고
    • Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?
    • Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998;124:958-964.
    • (1998) Surgery , vol.124 , pp. 958-964
    • Hay, I.D.1    Grant, C.S.2    Bergstralh, E.J.3
  • 106
    • 2442495444 scopus 로고    scopus 로고
    • Extent of surgery for differentiated thyroid cancer
    • Dackiw AP, Zeiger M. Extent of surgery for differentiated thyroid cancer. Surg Clin North Am 2004;84:817-832.
    • (2004) Surg Clin North Am , vol.84 , pp. 817-832
    • Dackiw, A.P.1    Zeiger, M.2
  • 107
    • 0025973242 scopus 로고
    • Treating differentiated thyroid carcinoma: Where do we draw the line?
    • Mazzaferri EL. Treating differentiated thyroid carcinoma: where do we draw the line? Mayo Clin Proc 1991;66:105-111.
    • (1991) Mayo Clin Proc , vol.66 , pp. 105-111
    • Mazzaferri, E.L.1
  • 108
    • 0021354928 scopus 로고
    • Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment
    • Massin JP, Savoie JC, Garnier H, et al. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 1984;53:982-992.
    • (1984) Cancer , vol.53 , pp. 982-992
    • Massin, J.P.1    Savoie, J.C.2    Garnier, H.3
  • 109
    • 1642392071 scopus 로고    scopus 로고
    • Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer
    • Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 2004;114:393-402.
    • (2004) Laryngoscope , vol.114 , pp. 393-402
    • Shaha, A.R.1
  • 110
    • 0026327698 scopus 로고
    • Second operations for "completion" of thyroidectomy in treatment of differentiated thyroid cancer
    • discussion 939-940
    • DeGroot LJ, Kaplan EL. Second operations for "completion" of thyroidectomy in treatment of differentiated thyroid cancer. Surgery 1991;110:936-939; discussion 939-940.
    • (1991) Surgery , vol.110 , pp. 936-939
    • DeGroot, L.J.1    Kaplan, E.L.2
  • 111
    • 0026758760 scopus 로고
    • The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy
    • discussion 716-717
    • Pasieka JL, Thompson NW, McLeod MK, et al. The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg 1992;16:711-716; discussion 716-717.
    • (1992) World J Surg , vol.16 , pp. 711-716
    • Pasieka, J.L.1    Thompson, N.W.2    McLeod, M.K.3
  • 112
    • 0029849296 scopus 로고    scopus 로고
    • Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma
    • Scheumann GF, Seeliger H, Musholt TJ, et al. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 1996;162:677-684.
    • (1996) Eur J Surg , vol.162 , pp. 677-684
    • Scheumann, G.F.1    Seeliger, H.2    Musholt, T.J.3
  • 114
    • 0034850798 scopus 로고    scopus 로고
    • Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients
    • Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001;11:877-881.
    • (2001) Thyroid , vol.11 , pp. 877-881
    • Pacini, F.1    Elisei, R.2    Capezzone, M.3
  • 115
  • 116
    • 15644377401 scopus 로고    scopus 로고
    • Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience
    • Dralle H, Gimm O, Simon D, et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 1998;22:744-750.
    • (1998) World J Surg , vol.22 , pp. 744-750
    • Dralle, H.1    Gimm, O.2    Simon, D.3
  • 117
    • 0030039055 scopus 로고    scopus 로고
    • Optimal surgery for papillary thyroid carcinoma
    • Udelsman R, Lakatos E, Ladenson P. Optimal surgery for papillary thyroid carcinoma. World J Surg 1996;20:88-93.
    • (1996) World J Surg , vol.20 , pp. 88-93
    • Udelsman, R.1    Lakatos, E.2    Ladenson, P.3
  • 118
    • 0031863353 scopus 로고    scopus 로고
    • Hypocalcemia following thyroid surgery: Incidence and prediction of outcome
    • Pattou F, Combemale F, Fabre S, et al. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg 1998;22:718-724.
    • (1998) World J Surg , vol.22 , pp. 718-724
    • Pattou, F.1    Combemale, F.2    Fabre, S.3
  • 119
    • 0032470551 scopus 로고    scopus 로고
    • The importance of surgeon experience for clinical and economic outcomes from thyroidectomy
    • Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998;228:320-330.
    • (1998) Ann Surg , vol.228 , pp. 320-330
    • Sosa, J.A.1    Bowman, H.M.2    Tielsch, J.M.3
  • 120
    • 85047681191 scopus 로고    scopus 로고
    • Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer
    • Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-1463.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 1447-1463
    • Mazzaferri, E.L.1    Kloos, R.T.2
  • 121
    • 0030611976 scopus 로고    scopus 로고
    • Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma
    • Mazzaferri EL. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma. Thyroid 1997;7:265-271.
    • (1997) Thyroid , vol.7 , pp. 265-271
    • Mazzaferri, E.L.1
  • 123
    • 14844343863 scopus 로고    scopus 로고
    • The evolving role of (131)I for the treatment of differentiated thyroid carcinoma
    • Robbins RJ, Schlumberger MJ. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma. J Nucl Med 2005;46(Suppl 1):28S-37S.
    • (2005) J Nucl Med , vol.46 , Issue.SUPPL. 1
    • Robbins, R.J.1    Schlumberger, M.J.2
  • 124
    • 0031942042 scopus 로고    scopus 로고
    • Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma
    • Leger FA, Izembart M, Dagousset F, et al. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. Eur J Nucl Med 1998;25:242-246.
    • (1998) Eur J Nucl Med , vol.25 , pp. 242-246
    • Leger, F.A.1    Izembart, M.2    Dagousset, F.3
  • 125
    • 0030983929 scopus 로고    scopus 로고
    • Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma
    • Muratet JP, Giraud P, Daver A, et al. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. J Nucl Med 1997;38:1362-1368.
    • (1997) J Nucl Med , vol.38 , pp. 1362-1368
    • Muratet, J.P.1    Giraud, P.2    Daver, A.3
  • 126
    • 0002083634 scopus 로고    scopus 로고
    • Carcinoma of follicular epithelium: Radioiodine and other treatment outcomes
    • Braverman LE, Utiger RD, eds. Philadelphia, PA: Lippincott-Raven
    • Mazzaferri EL. Carcinoma of follicular epithelium: Radioiodine and other treatment outcomes. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott-Raven; 1996:922-945.
    • (1996) The Thyroid: A Fundamental and Clinical Text , pp. 922-945
    • Mazzaferri, E.L.1
  • 128
    • 0002621788 scopus 로고    scopus 로고
    • Radioiodine and external radiation therapy in the treatment of thyroid cancer
    • Fagin JA, ed. Boston, MA: Kluwer Academic
    • Brierley J, Maxon HR. Radioiodine and external radiation therapy in the treatment of thyroid cancer. In: Fagin JA, ed. Thyroid Cancer. Boston, MA: Kluwer Academic; 1998:285-317.
    • (1998) Thyroid Cancer , pp. 285-317
    • Brierley, J.1    Maxon, H.R.2
  • 129
    • 34447330738 scopus 로고    scopus 로고
    • Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer
    • Tuttle RM, Leboeuf R, Robbins RJ, et al. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. J Nucl Med 2006;47:1587-1591.
    • (2006) J Nucl Med , vol.47 , pp. 1587-1591
    • Tuttle, R.M.1    Leboeuf, R.2    Robbins, R.J.3
  • 131
    • 0026769603 scopus 로고
    • Radioiodine-131 therapy for well-differentiated thyroid cancer - A quantitative radiation dosimetric approach: Outcome and validation in 85 patients
    • Maxon HR III, Englaro EE, Thomas SR, et al. Radioiodine-131 therapy for well-differentiated thyroid cancer - a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992;33:1132-1136.
    • (1992) J Nucl Med , vol.33 , pp. 1132-1136
    • Maxon III, H.R.1    Englaro, E.E.2    Thomas, S.R.3
  • 132
    • 84961056233 scopus 로고
    • The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer
    • Benua RS, Cicale NR, Sonenberg M, Rawson RW. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med 1962;87:171-182.
    • (1962) Am J Roentgenol Radium Ther Nucl Med , vol.87 , pp. 171-182
    • Benua, R.S.1    Cicale, N.R.2    Sonenberg, M.3    Rawson, R.W.4
  • 133
    • 0028268001 scopus 로고
    • Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma
    • Sherman SI, Tielens ET, Sostre S, et al. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994;78:629-634.
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 629-634
    • Sherman, S.I.1    Tielens, E.T.2    Sostre, S.3
  • 134
    • 0042885561 scopus 로고    scopus 로고
    • Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
    • Pacini F, Molinaro E, Castagna MG, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003;88:3668-3673.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 3668-3673
    • Pacini, F.1    Molinaro, E.2    Castagna, M.G.3
  • 135
    • 0022388588 scopus 로고
    • Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
    • Oxf
    • Pacini F, Lari R, Mazzeo S, et al. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 1985;23:405-411.
    • (1985) Clin Endocrinol , vol.23 , pp. 405-411
    • Pacini, F.1    Lari, R.2    Mazzeo, S.3
  • 136
    • 0033341953 scopus 로고    scopus 로고
    • A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer
    • Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999;84:3877-3885.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 3877-3885
    • Haugen, B.R.1    Pacini, F.2    Reiners, C.3
  • 137
    • 24344489445 scopus 로고    scopus 로고
    • A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later
    • Kloos RT, Mazzaferri EL. A single recombinant human thyrotropin- stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 2005;90:5047-5057.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 5047-5057
    • Kloos, R.T.1    Mazzaferri, E.L.2
  • 138
    • 0030886175 scopus 로고    scopus 로고
    • Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma
    • Ladenson PW, Braverman LE, Mazzaferri EL, et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 1997;337:888-896.
    • (1997) N Engl J Med , vol.337 , pp. 888-896
    • Ladenson, P.W.1    Braverman, L.E.2    Mazzaferri, E.L.3
  • 139
    • 0036281001 scopus 로고    scopus 로고
    • Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    • Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 2002;87:1490-1498.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 1490-1498
    • Mazzaferri, E.L.1    Kloos, R.T.2
  • 140
    • 38149106508 scopus 로고    scopus 로고
    • Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels
    • Castagna MG, Brilli L, Pilli T, et al. Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J Clin Endocrinol Metab 2008;93:76-81.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 76-81
    • Castagna, M.G.1    Brilli, L.2    Pilli, T.3
  • 141
    • 0030048306 scopus 로고    scopus 로고
    • Current status and performance goals for serum thyroglobulin assays
    • Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clin Chem 1996;42:164-173. (Pubitemid 26030404)
    • (1996) Clinical Chemistry , vol.42 , Issue.1 , pp. 164-173
    • Spencer, C.A.1    Takeuchi, M.2    Kazarosyan, M.3
  • 142
    • 41149095035 scopus 로고    scopus 로고
    • Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
    • Spencer CA, Lopresti JS. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 2008;4:223-233.
    • (2008) Nat Clin Pract Endocrinol Metab , vol.4 , pp. 223-233
    • Spencer, C.A.1    Lopresti, J.S.2
  • 143
    • 0031791032 scopus 로고    scopus 로고
    • Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma
    • Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998;83:1121-1127.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 1121-1127
    • Spencer, C.A.1    Takeuchi, M.2    Kazarosyan, M.3
  • 144
    • 0036373868 scopus 로고    scopus 로고
    • Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation
    • Oxf
    • Chung JK, Park YJ, Kim TY, et al. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 2002;57:215-221.
    • (2002) Clin Endocrinol , vol.57 , pp. 215-221
    • Chung, J.K.1    Park, Y.J.2    Kim, T.Y.3
  • 145
    • 1642453721 scopus 로고    scopus 로고
    • Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
    • Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003;139:346-351.
    • (2003) Ann Intern Med , vol.139 , pp. 346-351
    • Chiovato, L.1    Latrofa, F.2    Braverman, L.E.3
  • 146
    • 59449083096 scopus 로고    scopus 로고
    • Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer
    • Milas M, Barbosa GF, Mitchell J, et al. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Ann Surg Oncol 2009;16:473-480.
    • (2009) Ann Surg Oncol , vol.16 , pp. 473-480
    • Milas, M.1    Barbosa, G.F.2    Mitchell, J.3
  • 147
    • 55249098901 scopus 로고    scopus 로고
    • Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance
    • Barbosa GF, Milas M. Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance. Expert Rev Anticancer Ther 2008;8:1415-1424.
    • (2008) Expert Rev Anticancer Ther , vol.8 , pp. 1415-1424
    • Barbosa, G.F.1    Milas, M.2
  • 148
    • 0032461020 scopus 로고    scopus 로고
    • Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood
    • Ringel MD, Ladenson PW, Levine MA. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998;83:4435-4442.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 4435-4442
    • Ringel, M.D.1    Ladenson, P.W.2    Levine, M.A.3
  • 149
    • 0842269795 scopus 로고    scopus 로고
    • Molecular detection of thyroid cancer: Differentiating "signal" and "noise" in clinical assays
    • Ringel MD. Molecular detection of thyroid cancer: differentiating "signal" and "noise" in clinical assays. J Clin Endocrinol Metab 2004;89:29-32.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 29-32
    • Ringel, M.D.1
  • 151
    • 0022547135 scopus 로고
    • Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma
    • Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986;63:960-967.
    • (1986) J Clin Endocrinol Metab , vol.63 , pp. 960-967
    • Schlumberger, M.1    Tubiana, M.2    De Vathaire, F.3
  • 152
    • 0023603320 scopus 로고
    • Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
    • Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-1891.
    • (1987) J Nucl Med , vol.28 , pp. 1888-1891
    • Pacini, F.1    Lippi, F.2    Formica, N.3
  • 153
    • 0029006508 scopus 로고
    • Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
    • Pineda JD, Lee T, Ain K, et al. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995;80:1488-1492.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 1488-1492
    • Pineda, J.D.1    Lee, T.2    Ain, K.3
  • 154
    • 0029034183 scopus 로고
    • Treating high thyroglobulin with radioiodine: A magic bullet or a shot in the dark?
    • Mazzaferri EL. Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? J Clin Endocrinol Metab 1995;80:1485-1487.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 1485-1487
    • Mazzaferri, E.L.1
  • 155
    • 0034840812 scopus 로고    scopus 로고
    • Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: Comparison of patients treated with high (131) I activities versus untreated patients
    • Pacini F, Agate L, Elisei R, et al. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131) I activities versus untreated patients. J Clin Endocrinol Metab 2001;86:4092-4097.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 4092-4097
    • Pacini, F.1    Agate, L.2    Elisei, R.3
  • 157
    • 0036957966 scopus 로고    scopus 로고
    • Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer
    • McGriff NJ, Csako G, Gourgiotis L, et al. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 2002;34:554-564.
    • (2002) Ann Med , vol.34 , pp. 554-564
    • McGriff, N.J.1    Csako, G.2    Gourgiotis, L.3
  • 158
    • 0029827464 scopus 로고    scopus 로고
    • Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer
    • Pujol P, Daures JP, Nsakala N, et al. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81:4318-4323.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 4318-4323
    • Pujol, P.1    Daures, J.P.2    Nsakala, N.3
  • 159
    • 13144261746 scopus 로고    scopus 로고
    • Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry
    • Cooper DS, Specker B, Ho M, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 1998;8:737-744.
    • (1998) Thyroid , vol.8 , pp. 737-744
    • Cooper, D.S.1    Specker, B.2    Ho, M.3
  • 160
    • 0026757790 scopus 로고
    • Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer
    • Burmeister LA, Goumaz MO, Mariash CN, Oppenheimer JH. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 1992;75:344-350.
    • (1992) J Clin Endocrinol Metab , vol.75 , pp. 344-350
    • Burmeister, L.A.1    Goumaz, M.O.2    Mariash, C.N.3    Oppenheimer, J.H.4
  • 161
    • 33845444316 scopus 로고    scopus 로고
    • Outcomes of patients with differentiated thyroid carcinoma following initial therapy
    • Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006;16:1229-1242.
    • (2006) Thyroid , vol.16 , pp. 1229-1242
    • Jonklaas, J.1    Sarlis, N.J.2    Litofsky, D.3
  • 162
    • 0345873412 scopus 로고    scopus 로고
    • Multicenter study differentiated thyroid carcinoma (MSDS). Diminished acceptance of adjuvant external beam radiotherapy
    • Biermann M, Pixberg MK, Schuck A, et al. Multicenter study differentiated thyroid carcinoma (MSDS). Diminished acceptance of adjuvant external beam radiotherapy. Nuklearmedizin 2003;42:244-250.
    • (2003) Nuklearmedizin , vol.42 , pp. 244-250
    • Biermann, M.1    Pixberg, M.K.2    Schuck, A.3
  • 163
    • 0030030103 scopus 로고    scopus 로고
    • Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
    • Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996;77:172-180.
    • (1996) Cancer , vol.77 , pp. 172-180
    • Farahati, J.1    Reiners, C.2    Stuschke, M.3
  • 164
    • 0023695539 scopus 로고
    • Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
    • Simpson WJ, Panzarella T, Carruthers JS, et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988;14:1063-1075.
    • (1988) Int J Radiat Oncol Biol Phys , vol.14 , pp. 1063-1075
    • Simpson, W.J.1    Panzarella, T.2    Carruthers, J.S.3
  • 165
    • 0030664131 scopus 로고    scopus 로고
    • Prognosis and treatment of brain metastases in thyroid carcinoma
    • Chiu AC, Delpassand ES, Sherman SI. Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 1997;82:3637-3642.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 3637-3642
    • Chiu, A.C.1    Delpassand, E.S.2    Sherman, S.I.3
  • 166
    • 0025650377 scopus 로고
    • Chemotherapy in metastatic nonanaplastic thyroid cancer: Experience at the Institut Gustave-Roussy
    • Droz JP, Schlumberger M, Rougier P, et al. Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy. Tumori 1990;76:480-483.
    • (1990) Tumori , vol.76 , pp. 480-483
    • Droz, J.P.1    Schlumberger, M.2    Rougier, P.3
  • 167
    • 0023191605 scopus 로고
    • Chemotherapy of thyroid carcinoma
    • Ahuja S, Ernst H. Chemotherapy of thyroid carcinoma. J Endocrinol Invest 1987;10:303-310.
    • (1987) J Endocrinol Invest , vol.10 , pp. 303-310
    • Ahuja, S.1    Ernst, H.2
  • 168
    • 33744961755 scopus 로고    scopus 로고
    • Phase II study of celecoxib in metastatic differentiated thyroid carcinoma
    • Mrozek E, Kloos RT, Ringel MD, et al. Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91:2201-2204.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 2201-2204
    • Mrozek, E.1    Kloos, R.T.2    Ringel, M.D.3
  • 169
    • 34347235531 scopus 로고    scopus 로고
    • Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors
    • Rosen LS, Kurzrock R, Mulay M, et al. Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors. J Clin Oncol 2007;25:2369-2376.
    • (2007) J Clin Oncol , vol.25 , pp. 2369-2376
    • Rosen, L.S.1    Kurzrock, R.2    Mulay, M.3
  • 170
    • 46449117698 scopus 로고    scopus 로고
    • Motesanib diphosphate in progressive differentiated thyroid cancer
    • Sherman SI, Wirth LJ, Droz JP, et al. Motesanib diphosphate in progressive differentiated thyroid cancer. N Engl J Med 2008;359:31-42.
    • (2008) N Engl J Med , vol.359 , pp. 31-42
    • Sherman, S.I.1    Wirth, L.J.2    Droz, J.P.3
  • 171
    • 63849265332 scopus 로고    scopus 로고
    • Phase II trial of sorafenib in metastatic thyroid cancer
    • Kloos RT, Ringel MD, Knopp MV, et al. Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol 2009;27:1675-1684.
    • (2009) J Clin Oncol , vol.27 , pp. 1675-1684
    • Kloos, R.T.1    Ringel, M.D.2    Knopp, M.V.3
  • 172
    • 33749259546 scopus 로고    scopus 로고
    • Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study
    • [abstract]. Abstract 5534
    • Kloos R, Ringel M, Knopp M, et al. Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): updated results of a phase II study [abstract]. J Clin Oncol 2006;24(Suppl 1):Abstract 5534.
    • (2006) J Clin Oncol , vol.24 , Issue.SUPPL. 1
    • Kloos, R.1    Ringel, M.2    Knopp, M.3
  • 173
    • 50649095250 scopus 로고    scopus 로고
    • Phase II trial of sorafenib in advanced thyroid cancer
    • Gupta-Abramson V, Troxel AB, Nellore A, et al. Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol 2008;26:4714-4719.
    • (2008) J Clin Oncol , vol.26 , pp. 4714-4719
    • Gupta-Abramson, V.1    Troxel, A.B.2    Nellore, A.3
  • 174
    • 65749087602 scopus 로고    scopus 로고
    • Phase 2 study of sunitinib in refractory thyroid cancer
    • [abstract]. Abstract 6025
    • Cohen EE, Needles BM, Cullen KJ, et al. Phase 2 study of sunitinib in refractory thyroid cancer [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 6025.
    • (2008) J Clin Oncol , vol.26 , Issue.SUPPL. 1
    • Cohen, E.E.1    Needles, B.M.2    Cullen, K.J.3
  • 175
    • 70349300777 scopus 로고    scopus 로고
    • Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC)
    • [abstract]. Abstract 6062
    • Goulart B, Carr L, Martins RG, et al. Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC) [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 6062.
    • (2008) J Clin Oncol , vol.26 , Issue.SUPPL. 1
    • Goulart, B.1    Carr, L.2    Martins, R.G.3
  • 176
    • 50649095801 scopus 로고    scopus 로고
    • Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study
    • Cohen EE, Rosen LS, Vokes EE, et al. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol 2008;26:4708-4713.
    • (2008) J Clin Oncol , vol.26 , pp. 4708-4713
    • Cohen, E.E.1    Rosen, L.S.2    Vokes, E.E.3
  • 177
    • 67649389177 scopus 로고    scopus 로고
    • Phase II study of lenalidomide in distantly metastatic, rapidly progressive, and radioiodineunresponsive thyroid carcinomas: Preliminary results
    • [abstract]. Abstract 6027
    • Ain KB, Lee C, Holbrook KM, et al. Phase II study of lenalidomide in distantly metastatic, rapidly progressive, and radioiodineunresponsive thyroid carcinomas: preliminary results [abstract]. J Clin Oncol 2008;26:Abstract 6027.
    • (2008) J Clin Oncol , vol.26
    • Ain, K.B.1    Lee, C.2    Holbrook, K.M.3
  • 178
    • 36549015772 scopus 로고    scopus 로고
    • Novel chemotherapy options for advanced thyroid tumors: Small molecules offer great hope
    • Deshpande HA, Gettinger SN, Sosa JA. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope. Curr Opin Oncol 2008;20:19-24.
    • (2008) Curr Opin Oncol , vol.20 , pp. 19-24
    • Deshpande, H.A.1    Gettinger, S.N.2    Sosa, J.A.3
  • 179
    • 34447339642 scopus 로고    scopus 로고
    • Investigational therapies for metastatic thyroid carcinoma
    • Tuttle RM, Leboeuf R. Investigational therapies for metastatic thyroid carcinoma. J Natl Compr Canc Netw 2007;5:641-646.
    • (2007) J Natl Compr Canc Netw , vol.5 , pp. 641-646
    • Tuttle, R.M.1    Leboeuf, R.2
  • 181
    • 10744223753 scopus 로고    scopus 로고
    • Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer
    • Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003;134:946-954.
    • (2003) Surgery , vol.134 , pp. 946-954
    • Kouvaraki, M.A.1    Shapiro, S.E.2    Fornage, B.D.3
  • 182
    • 70249141701 scopus 로고    scopus 로고
    • Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma
    • Moo TA, Umunna B, Kato M, et al. Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 2009;250:403-408.
    • (2009) Ann Surg , vol.250 , pp. 403-408
    • Moo, T.A.1    Umunna, B.2    Kato, M.3
  • 183
    • 70349303960 scopus 로고    scopus 로고
    • Routine bilateral central lymph node clearance for papillary thyroid cancer
    • Sadowski BM, Snyder SK, Lairmore TC. Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 2009;146:696-703.
    • (2009) Surgery , vol.146 , pp. 696-703
    • Sadowski, B.M.1    Snyder, S.K.2    Lairmore, T.C.3
  • 184
    • 51449104287 scopus 로고    scopus 로고
    • Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience
    • Palestini N, Borasi A, Cestino L, et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg 2008;393:693-698.
    • (2008) Langenbecks Arch Surg , vol.393 , pp. 693-698
    • Palestini, N.1    Borasi, A.2    Cestino, L.3
  • 185
    • 16844381563 scopus 로고    scopus 로고
    • Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer
    • Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 2005;12:81-89.
    • (2005) Ann Surg Oncol , vol.12 , pp. 81-89
    • Haigh, P.I.1    Urbach, D.R.2    Rotstein, L.E.3
  • 186
    • 34548189836 scopus 로고    scopus 로고
    • Extent of surgery affects survival for papillary thyroid cancer
    • Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375-381.
    • (2007) Ann Surg , vol.246 , pp. 375-381
    • Bilimoria, K.Y.1    Bentrem, D.J.2    Ko, C.Y.3
  • 188
    • 0038298276 scopus 로고    scopus 로고
    • Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma
    • Eustatia-Rutten CF, Romijn JA, Guijt MJ, et al. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003;88:3184-3189.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 3184-3189
    • Eustatia-Rutten, C.F.1    Romijn, J.A.2    Guijt, M.J.3
  • 189
    • 0036122254 scopus 로고    scopus 로고
    • Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma
    • Van Nostrand D, Atkins F, Yeganeh F, et al. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid 2002;12:121-134.
    • (2002) Thyroid , vol.12 , pp. 121-134
    • Van Nostrand, D.1    Atkins, F.2    Yeganeh, F.3
  • 190
    • 0035253303 scopus 로고    scopus 로고
    • A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature
    • Thompson LD, Wieneke JA, Paal E, et al. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 2001;91:505-524.
    • (2001) Cancer , vol.91 , pp. 505-524
    • Thompson, L.D.1    Wieneke, J.A.2    Paal, E.3
  • 191
    • 0034856238 scopus 로고    scopus 로고
    • Hurthle cell tumor of the thyroid: Analysis of 188 cases
    • Sugino K, Ito K, Mimura T, et al. Hurthle cell tumor of the thyroid: analysis of 188 cases. World J Surg 2001;25:1160-1163.
    • (2001) World J Surg , vol.25 , pp. 1160-1163
    • Sugino, K.1    Ito, K.2    Mimura, T.3
  • 192
    • 0026888102 scopus 로고
    • Hurthle cell (oxyphilic) papillary thyroid carcinoma: A variant with more aggressive biologic behavior
    • Herrera MF, Hay ID, Wu PS, et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg 1992;16:669-674.
    • (1992) World J Surg , vol.16 , pp. 669-674
    • Herrera, M.F.1    Hay, I.D.2    Wu, P.S.3
  • 193
    • 33644977631 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches
    • Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006;13:453-464.
    • (2006) Ann Surg Oncol , vol.13 , pp. 453-464
    • Are, C.1    Shaha, A.R.2
  • 194
    • 15744362272 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors
    • Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005;103:1330-1335.
    • (2005) Cancer , vol.103 , pp. 1330-1335
    • Kebebew, E.1    Greenspan, F.S.2    Clark, O.H.3
  • 195
    • 0031050368 scopus 로고    scopus 로고
    • p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells
    • Moretti F, Farsetti A, Soddu S, et al. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene 1997;14:729-740.
    • (1997) Oncogene , vol.14 , pp. 729-740
    • Moretti, F.1    Farsetti, A.2    Soddu, S.3
  • 196
    • 78951493348 scopus 로고    scopus 로고
    • Anaplastic carcinoma: Clinical aspects
    • Wartofsky L, Van Nostrand D, eds. 2nd ed. Totowa, NJ: Humana Press
    • Sherman SI. Anaplastic carcinoma: clinical aspects. In: Wartofsky L, Van Nostrand D, eds. Thyroid Cancer: A Comprehensive Guide to Clinical Management, 2nd ed. Totowa, NJ: Humana Press; 2006:629-632.
    • (2006) Thyroid Cancer: A Comprehensive Guide to Clinical Management , pp. 629-632
    • Sherman, S.I.1
  • 197
    • 0025359922 scopus 로고
    • CT evaluation of anaplastic thyroid carcinoma
    • Takashima S, Morimoto S, Ikezoe J, et al. CT evaluation of anaplastic thyroid carcinoma. AJR Am J Roentgenol 1990;154:1079-1085.
    • (1990) AJR Am J Roentgenol , vol.154 , pp. 1079-1085
    • Takashima, S.1    Morimoto, S.2    Ikezoe, J.3
  • 198
    • 33746659057 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid
    • Untch BR, Olson JA Jr. Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Surg Oncol Clin N Am 2006;15:661-679.
    • (2006) Surg Oncol Clin N Am , vol.15 , pp. 661-679
    • Untch, B.R.1    Olson Jr., J.A.2
  • 199
    • 0025327895 scopus 로고
    • Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases
    • Venkatesh YS, Ordonez NG, Schultz PN, et al. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990;66:321-330.
    • (1990) Cancer , vol.66 , pp. 321-330
    • Venkatesh, Y.S.1    Ordonez, N.G.2    Schultz, P.N.3
  • 200
    • 0026522308 scopus 로고
    • Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy
    • Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 1992;18:83-88.
    • (1992) Eur J Surg Oncol , vol.18 , pp. 83-88
    • Junor, E.J.1    Paul, J.2    Reed, N.S.3
  • 201
    • 0035666788 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: A 50-year experience at a single institution
    • McIver B, Hay ID, Giuffrida DF, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001;130:1028-1034.
    • (2001) Surgery , vol.130 , pp. 1028-1034
    • McIver, B.1    Hay, I.D.2    Giuffrida, D.F.3
  • 202
    • 33750067044 scopus 로고    scopus 로고
    • Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twicedaily fractionation regimens
    • Wang Y, Tsang R, Asa S, et al. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twicedaily fractionation regimens. Cancer 2006;107:1786-1792.
    • (2006) Cancer , vol.107 , pp. 1786-1792
    • Wang, Y.1    Tsang, R.2    Asa, S.3
  • 203
    • 0023232840 scopus 로고
    • Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy
    • Kim JH, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 1987;60:2372-2375.
    • (1987) Cancer , vol.60 , pp. 2372-2375
    • Kim, J.H.1    Leeper, R.D.2
  • 204
    • 11844262036 scopus 로고    scopus 로고
    • Anaplastic giant cell thyroid carcinoma
    • Wallin G, Lundell G, Tennvall J. Anaplastic giant cell thyroid carcinoma. Scand J Surg 2004;93:272-277.
    • (2004) Scand J Surg , vol.93 , pp. 272-277
    • Wallin, G.1    Lundell, G.2    Tennvall, J.3
  • 205
    • 0031752682 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches
    • Ain KB. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 1998;8:715-726.
    • (1998) Thyroid , vol.8 , pp. 715-726
    • Ain, K.B.1
  • 206
    • 0033840233 scopus 로고    scopus 로고
    • Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-sixhour infusion
    • Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group
    • Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-sixhour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 2000;10:587-594.
    • (2000) Thyroid , vol.10 , pp. 587-594
    • Ain, K.B.1    Egorin, M.J.2    DeSimone, P.A.3
  • 207
    • 0842311621 scopus 로고    scopus 로고
    • Vascular targeting agents as cancer therapeutics
    • Thorpe PE. Vascular targeting agents as cancer therapeutics. Clin Cancer Res 2004;10:415-427.
    • (2004) Clin Cancer Res , vol.10 , pp. 415-427
    • Thorpe, P.E.1
  • 208
    • 65549128212 scopus 로고    scopus 로고
    • Anaplastic thyroid cancer: Molecular pathogenesis and emerging therapies
    • Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 2009;16:17-44.
    • (2009) Endocr Relat Cancer , vol.16 , pp. 17-44
    • Smallridge, R.C.1    Marlow, L.A.2    Copland, J.A.3
  • 209
    • 0037096814 scopus 로고    scopus 로고
    • A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer
    • Dowlati A, Robertson K, Cooney M, et al. A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. Cancer Res 2002;62:3408-3416.
    • (2002) Cancer Res , vol.62 , pp. 3408-3416
    • Dowlati, A.1    Robertson, K.2    Cooney, M.3
  • 210
    • 33750299899 scopus 로고    scopus 로고
    • Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma (ATC)
    • [abstract]. Abstract 5580
    • Cooney MM, Savvides P, Agarwala S, et al. Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma (ATC) [abstract]. J Clin Oncol 2006;24:Abstract 5580.
    • (2006) J Clin Oncol , vol.24
    • Cooney, M.M.1    Savvides, P.2    Agarwala, S.3
  • 211
    • 62349137638 scopus 로고    scopus 로고
    • A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome
    • Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid 2009;19:233-240.
    • (2009) Thyroid , vol.19 , pp. 233-240
    • Mooney, C.J.1    Nagaiah, G.2    Fu, P.3
  • 212
    • 0036795865 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: Comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups
    • Heron DE, Karimpour S, Grigsby PW. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups. Am J Clin Oncol 2002;25:442-446.
    • (2002) Am J Clin Oncol , vol.25 , pp. 442-446
    • Heron, D.E.1    Karimpour, S.2    Grigsby, P.W.3
  • 213
    • 50049109956 scopus 로고    scopus 로고
    • Treatment outcomes in anaplastic thyroid carcinoma: Survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy
    • Yau T, Lo CY, Epstein RJ, et al. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy. Ann Surg Oncol 2008;15:2500-2505.
    • (2008) Ann Surg Oncol , vol.15 , pp. 2500-2505
    • Yau, T.1    Lo, C.Y.2    Epstein, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.